Lantheus
LNTH
Hutchmed (China)
HCM
Workday
WDAY
DexCom
DXCM
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
(FY)Nov 30, 2024 | (Q2)May 31, 2024 | (FY)Nov 30, 2023 | (Q2)May 31, 2023 | (FY)Nov 30, 2022 | (Q2)May 31, 2022 | (FY)Nov 30, 2021 | (Q2)May 31, 2021 | (FY)Nov 30, 2020 | (Q2)May 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash cash equivalents and federal funds sold | ---- | -39.65%752K | 10.98%839K | -25.48%1.25M | -47.65%756K | -36.38%1.67M | 237.38%1.44M | 16.44%2.63M | -81.03%428K | 1.21%2.26M |
-Cash and cash equivalents | ---- | -50.00%500K | 16.63%589K | -25.04%1M | -56.20%505K | -39.00%1.33M | 574.27%1.15M | 9.35%2.19M | -91.45%171K | 0.00%2M |
-Restricted cash and investments | ---- | 2.44%252K | -0.40%250K | -27.22%246K | -13.75%251K | -23.36%338K | 13.23%291K | 71.60%441K | 0.39%257K | 11.74%257K |
Receivables | 68.24%5.41M | -5.76%2.22M | -5.69%3.22M | -4.92%2.36M | 103.10%3.41M | 90.92%2.48M | 5.33%1.68M | 154.90%1.3M | 90.79%1.6M | -30.80%510K |
-Available for sale securities | --12.68M | 38.15%34.01M | ---- | --24.62M | --1.78M | ---- | ---- | ---- | ---- | 9,164.38%56.7M |
Deferred costs | -4.35%615K | -26.87%1.04M | 16.70%643K | 28.91%1.42M | -3.50%551K | 11.68%1.1M | 1.42%571K | -18.53%985K | 0.18%563K | 17.04%1.21M |
Total assets | 46.31%3.55B | 53.05%2.74B | 21.10%2.43B | -15.77%1.79B | 23.87%2B | 28.88%2.13B | 29.16%1.62B | 23.35%1.65B | -58.26%1.25B | -61.68%1.34B |
Liabilities | ||||||||||
Payables | -7.30%11.09M | 37.05%8.71M | 72.40%11.97M | -14.78%6.36M | 29.28%6.94M | -50.05%7.46M | 2.05%5.37M | 25.53%14.93M | -61.06%5.26M | -0.84%11.89M |
-Accounts payable | ---- | ---- | 33,240.00%5M | ---- | -25.00%15K | -93.34%667K | -98.52%20K | 94.78%10.01M | --1.35M | --5.14M |
-Total tax payable | --433K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other payable | 53.04%10.66M | 37.05%8.71M | 0.56%6.97M | -6.41%6.36M | 29.48%6.93M | 38.00%6.79M | 36.70%5.35M | -27.15%4.92M | -63.68%3.91M | -43.68%6.76M |
Long term debt and capital lease obligation | 37.97%474.93M | 39.78%409.5M | 11.27%344.22M | -24.85%292.96M | -3.82%309.35M | 22.94%389.85M | 37.08%321.63M | 75.62%317.1M | -65.96%234.63M | -76.37%180.55M |
Derivative product liabilities | ---- | ---- | ---- | ---- | --45K | ---- | ---- | --404K | ---- | ---- |
Preferred securities outside stock equity | 0.45%152.25M | 37.55%151.75M | 37.52%151.57M | 21.95%110.33M | 9.74%110.22M | -9.83%90.47M | -25.65%100.43M | -48.21%100.33M | -57.28%135.09M | -38.66%193.71M |
Other liabilities | 20.01%8.71M | 35.71%7.81M | 18.14%7.26M | 34.73%5.76M | 47.80%6.14M | 3.44%4.27M | -15.48%4.16M | -30.92%4.13M | -61.18%4.92M | -54.93%5.98M |
Total liabilities | 55.41%1.01B | 54.99%778.17M | 16.78%650.06M | -20.11%502.09M | 13.16%556.64M | 26.78%628.5M | 29.43%491.9M | 11.80%495.75M | -69.51%380.06M | -68.46%443.44M |
Shareholders'equity | ||||||||||
Share capital | 0.00%169K | 24.26%169K | 24.26%169K | 0.00%136K | 7.94%136K | 7.94%136K | 0.00%126K | 0.00%126K | 0.00%126K | 0.00%126K |
-common stock | 0.00%169K | 24.26%169K | 24.26%169K | 0.00%136K | 7.94%136K | 7.94%136K | 0.00%126K | 0.00%126K | 0.00%126K | 0.00%126K |
Paid-in capital | 0.00%2.61B | 41.26%2.61B | 37.12%2.61B | -0.35%1.85B | 4.72%1.9B | -0.42%1.85B | -4.33%1.82B | -3.92%1.86B | -4.88%1.9B | -10.33%1.94B |
Retained earnings | 91.81%-68.17M | -15.77%-645.88M | -82.81%-832.1M | -56.95%-557.89M | 34.12%-455.17M | 49.73%-355.45M | 32.70%-690.95M | 32.21%-707.14M | -324.57%-1.03B | -1,292.15%-1.04B |
Total stockholders'equity | 42.98%2.54B | 52.29%1.96B | 22.76%1.78B | -13.94%1.29B | 28.54%1.45B | 29.78%1.5B | 29.05%1.13B | 29.07%1.15B | -50.27%872.91M | -57.11%894.5M |
Total equity | 42.98%2.54B | 52.29%1.96B | 22.76%1.78B | -13.94%1.29B | 28.54%1.45B | 29.78%1.5B | 29.05%1.13B | 29.07%1.15B | -50.27%872.91M | -57.11%894.5M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |